| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain A, 2-oxoglutarate Oxygenase | 6 | 0 | 0 | 6 |
| Microtubule-associated protein tau | 4 | 0 | 0 | 4 |
| thioredoxin glutathione reductase | 5 | 0 | 0 | 5 |
| Smad3 | 1 | 0 | 0 | 1 |
| euchromatic histone-lysine N-methyltransferase 2 | 12 | 0 | 0 | 12 |
| microphthalmia-associated transcription factor isoform 9 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 1 | 0 | 5 | 0 | 6 |
| Carbonic anhydrase 2 | 0 | 5 | 0 | 6 |
| Tyrosine-protein phosphatase non-receptor type 1 | 0 | 0 | 1 | 1 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 6 | 0 | 0 | 6 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| thioredoxin reductase | 7 | 0 | 0 | 7 |
| phosphopantetheinyl transferase | 3 | 0 | 0 | 3 |
| NFKB1 protein, partial | 2 | 0 | 0 | 2 |
| GLS protein | 6 | 0 | 0 | 6 |
| thyroid stimulating hormone receptor | 9 | 0 | 0 | 9 |
| alpha-galactosidase | 1 | 0 | 0 | 1 |
| cytochrome P450 2C19 precursor | 2 | 0 | 0 | 2 |
| chromobox protein homolog 1 | 7 | 0 | 0 | 7 |
| flap endonuclease 1 | 3 | 0 | 0 | 3 |
| DNA polymerase iota isoform a (long) | 4 | 0 | 0 | 4 |
| muscarinic acetylcholine receptor M1 | 6 | 0 | 0 | 6 |
| lethal factor (plasmid) | 5 | 0 | 0 | 5 |
| Cytochrome P450 3A4 | 0 | 3 | 0 | 4 |
| Nitric oxide synthase, endothelial | 0 | 0 | 0 | 2 |
| Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 0 | 1 | 3 |
| Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
| ATP-dependent phosphofructokinase | 4 | 0 | 0 | 4 |
| Chain A, Hyaluronidase, phage associated | 0 | 1 | 0 | 1 |
| acetylcholinesterase | 2 | 0 | 0 | 2 |
| RAR-related orphan receptor gamma | 7 | 0 | 0 | 7 |
| GLI family zinc finger 3 | 12 | 0 | 0 | 12 |
| AR protein | 14 | 0 | 0 | 14 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 7 | 0 | 0 | 7 |
| glucocorticoid receptor [Homo sapiens] | 10 | 0 | 0 | 10 |
| retinoic acid nuclear receptor alpha variant 1 | 12 | 0 | 0 | 12 |
| estrogen-related nuclear receptor alpha | 11 | 0 | 0 | 11 |
| estrogen nuclear receptor alpha | 18 | 0 | 0 | 18 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 8 | 0 | 0 | 8 |
| IDH1 | 3 | 0 | 0 | 3 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 3 | 0 | 0 | 3 |
| thyroid hormone receptor beta isoform 2 | 6 | 0 | 0 | 6 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 8 | 0 | 0 | 8 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
| geminin | 8 | 0 | 0 | 8 |
| lamin isoform A-delta10 | 7 | 0 | 0 | 7 |
| Polyphenol oxidase 2 | 0 | 3 | 0 | 3 |
| Pancreatic alpha-amylase | 0 | 2 | 0 | 2 |
| Albumin | 0 | 1 | 0 | 1 |
| Urease | 0 | 1 | 0 | 1 |
| Prolyl 4-hydroxylase subunit alpha-1 | 0 | 0 | 0 | 1 |
| Tyrosinase | 0 | 1 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 0 | 1 | 1 |
| Spike glycoprotein | 2 | 0 | 0 | 2 |
| Hyaluronate lyase | 0 | 1 | 0 | 1 |
| Prolyl hydroxylase EGLN2 | 0 | 0 | 0 | 1 |
| Egl nine homolog 1 | 0 | 0 | 0 | 1 |
| Prolyl hydroxylase EGLN3 | 0 | 0 | 0 | 1 |
| Hypoxia-inducible factor 1-alpha inhibitor | 0 | 0 | 0 | 1 |
| Solute carrier family 23 member 1 | 0 | 1 | 0 | 1 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 3 | 0 | 0 | 3 |
| Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
| Chain A, HADH2 protein | 6 | 0 | 0 | 6 |
| Chain B, HADH2 protein | 6 | 0 | 0 | 6 |
| GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
| ras protein, partial | 0 | 0 | 1 | 1 |
| interleukin 8 | 5 | 0 | 0 | 5 |
| aldehyde dehydrogenase 1 family, member A1 | 13 | 0 | 0 | 13 |
| hypothetical protein, conserved | 1 | 0 | 0 | 1 |
| EWS/FLI fusion protein | 6 | 0 | 0 | 6 |
| cytochrome P450 2D6 | 2 | 0 | 0 | 2 |
| glucocerebrosidase | 1 | 0 | 0 | 1 |
| peroxisome proliferator-activated receptor delta | 6 | 0 | 0 | 6 |
| Rac1 protein | 0 | 0 | 1 | 1 |
| cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
| Bloom syndrome protein isoform 1 | 4 | 0 | 0 | 4 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 3 | 0 | 0 | 3 |
| DNA polymerase kappa isoform 1 | 1 | 0 | 0 | 1 |
| Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
| ATP-binding cassette sub-family C member 3 | 0 | 11 | 0 | 11 |
| Multidrug resistance-associated protein 4 | 0 | 11 | 0 | 11 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Bile salt export pump | 0 | 16 | 0 | 16 |
| Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
| Fatty acid-binding protein, liver | 0 | 2 | 0 | 2 |
| Integrin beta-3 | 0 | 1 | 0 | 1 |
| Myeloperoxidase | 0 | 3 | 0 | 3 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
| Integrin alpha-IIb | 0 | 1 | 0 | 1 |
| Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 1 | 0 | 1 |
| Substance-P receptor | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 3 |
| Urotensin-2 receptor | 0 | 1 | 0 | 1 |
| 4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
| Nuclear receptor ROR-gamma | 3 | 0 | 0 | 3 |
| Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 5 | 2 | 0 | 7 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
| Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Canalicular multispecific organic anion transporter 1 | 0 | 11 | 0 | 11 |
| Sigma non-opioid intracellular receptor 1 | 0 | 0 | 1 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 0 | 1 | 1 |
| Carbonic anhydrase 4 | 0 | 1 | 0 | 2 |
| Carbonic anhydrase | 0 | 1 | 0 | 2 |
| Carbonic anhydrase 15 | 0 | 1 | 0 | 2 |
| Chain A, Cruzipain | 2 | 0 | 0 | 2 |
| TDP1 protein | 8 | 0 | 0 | 8 |
| cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 5 | 1 | 0 | 6 |
| Cytochrome P450 1A2 | 0 | 2 | 0 | 2 |
| DNA gyrase subunit B | 0 | 1 | 0 | 1 |
| DNA gyrase subunit A | 0 | 1 | 0 | 1 |
| DNA gyrase subunit B | 0 | 1 | 0 | 2 |
| DNA gyrase subunit A | 0 | 2 | 0 | 4 |
| DNA gyrase subunit B | 0 | 2 | 0 | 4 |
| DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 1 |
| DNA topoisomerase 4 subunit B | 0 | 1 | 0 | 2 |
| DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 2 |
| Cytochrome P450 2D6 | 0 | 2 | 0 | 2 |
| DNA topoisomerase 2-alpha | 0 | 1 | 0 | 4 |
| Cytochrome P450 2C9 | 0 | 5 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 5 | 1 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit delta | 5 | 1 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 5 | 1 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 5 | 1 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 5 | 1 | 0 | 6 |
| DNA gyrase subunit A | 0 | 1 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 5 | 1 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 5 | 1 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 5 | 1 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 5 | 1 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 5 | 1 | 0 | 6 |
| Cytochrome P450 2C19 | 0 | 2 | 0 | 2 |
| Multidrug resistance protein MdtK | 0 | 0 | 1 | 1 |
| Histamine H2 receptor | 2 | 0 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 5 | 1 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 5 | 1 | 0 | 6 |
| DNA gyrase subunit B | 0 | 3 | 0 | 3 |
| DNA gyrase subunit A | 0 | 3 | 0 | 3 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 2 | 0 | 7 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 4 | 0 | 5 |
| DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 1 |
| DNA topoisomerase 4 subunit B | 0 | 1 | 0 | 1 |
| Integrase | 0 | 1 | 0 | 1 |
| GABA theta subunit | 5 | 1 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit epsilon | 5 | 1 | 0 | 6 |
| endonuclease IV | 2 | 0 | 0 | 2 |
| dopamine D1 receptor | 3 | 0 | 0 | 3 |
| pregnane X receptor | 2 | 0 | 0 | 2 |
| progesterone receptor | 5 | 0 | 0 | 5 |
| regulator of G-protein signaling 4 | 2 | 0 | 0 | 2 |
| retinoid X nuclear receptor alpha | 7 | 0 | 0 | 7 |
| pregnane X nuclear receptor | 8 | 0 | 0 | 8 |
| peroxisome proliferator activated receptor gamma | 4 | 0 | 0 | 4 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 2 | 0 | 0 | 2 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 5 | 0 | 0 | 5 |
| peripheral myelin protein 22 isoform 1 | 2 | 0 | 0 | 2 |
| atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
| heat shock protein beta-1 | 1 | 0 | 0 | 1 |
| survival motor neuron protein isoform d | 2 | 0 | 0 | 2 |
| cytochrome P450 3A4 isoform 1 | 5 | 0 | 0 | 5 |
| M-phase phosphoprotein 8 | 3 | 0 | 0 | 3 |
| Glucocorticoid receptor | 0 | 6 | 2 | 13 |
| Sex hormone-binding globulin | 0 | 0 | 1 | 1 |
| Glycine receptor subunit alpha-1 | 0 | 6 | 0 | 6 |
| Corticosteroid-binding globulin | 0 | 2 | 0 | 2 |
| Glycine receptor subunit beta | 0 | 6 | 0 | 6 |
| Glycine receptor subunit alpha-2 | 0 | 6 | 0 | 6 |
| Glycine receptor subunit alpha-3 | 0 | 6 | 0 | 6 |
| Potassium voltage-gated channel subfamily A member 1 | 0 | 0 | 1 | 1 |
| TAR DNA-binding protein 43 | 3 | 0 | 0 | 3 |
| Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
| Cereblon isoform 4 | 0 | 2 | 0 | 2 |
| Insulin-like growth factor-binding protein 5 | 0 | 0 | 1 | 1 |
| Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
| Protein cereblon | 0 | 2 | 0 | 2 |
| Pantothenate synthetase | 0 | 2 | 0 | 2 |
| GALC protein | 1 | 0 | 0 | 1 |
| aryl hydrocarbon receptor | 5 | 0 | 0 | 5 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 3 | 0 | 0 | 3 |
| nuclear receptor subfamily 1, group I, member 2 | 4 | 0 | 0 | 4 |
| Interferon beta | 4 | 0 | 0 | 4 |
| Luciferase | 1 | 0 | 0 | 1 |
| nuclear receptor subfamily 1, group I, member 3 | 3 | 0 | 0 | 3 |
| 67.9K protein | 2 | 0 | 0 | 2 |
| bromodomain adjacent to zinc finger domain 2B | 3 | 0 | 0 | 3 |
| 3-oxoacyl-[acyl-carrier-protein] synthase 3 | 0 | 1 | 0 | 1 |
| cytochrome P450 2D6 isoform 1 | 2 | 0 | 0 | 2 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 1 | 0 | 0 | 1 |
| nuclear receptor ROR-gamma isoform 1 | 2 | 0 | 0 | 2 |
| histone acetyltransferase KAT2A isoform 1 | 2 | 0 | 0 | 2 |
| N-glycosylase/DNA lyase | 0 | 1 | 0 | 1 |
| Bile salt export pump | 0 | 6 | 0 | 6 |
| Formamidopyrimidine-DNA glycosylase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2A6 | 0 | 1 | 0 | 1 |
| Macrophage migration inhibitory factor | 0 | 1 | 0 | 1 |
| Endonuclease III-like protein 1 | 0 | 1 | 0 | 1 |
| Isocitrate lyase | 0 | 1 | 0 | 1 |
| Putative FAD-containing monooxygenase MymA | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Endonuclease 8-like 1 | 0 | 1 | 0 | 1 |
| Thioredoxin reductase | 0 | 1 | 0 | 1 |
| Histone H2A.x | 2 | 0 | 0 | 2 |
| vitamin D3 receptor isoform VDRA | 3 | 0 | 0 | 3 |
| thyroid hormone receptor beta isoform a | 2 | 0 | 0 | 2 |
| mitogen-activated protein kinase 1 | 2 | 0 | 0 | 2 |
| muscleblind-like protein 1 isoform 1 | 2 | 0 | 0 | 2 |
| Flavodoxin | 0 | 0 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
| Cellular tumor antigen p53 | 4 | 0 | 0 | 4 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
| Lanosterol 14-alpha demethylase | 0 | 2 | 0 | 2 |
| Albumin | 0 | 0 | 2 | 2 |
| Stromelysin-1 | 0 | 2 | 0 | 2 |
| Matrilysin | 0 | 1 | 0 | 1 |
| Multidrug transporter MdfA | 0 | 1 | 0 | 1 |
| Matrix metalloproteinase-9 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2J2 | 0 | 3 | 0 | 3 |
| Protein mono-ADP-ribosyltransferase PARP15 | 0 | 1 | 0 | 1 |
| Protein-arginine deiminase type-4 | 0 | 7 | 0 | 7 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
| glp-1 receptor, partial | 2 | 0 | 0 | 2 |
| thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
| lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
| Amyloid-beta precursor protein | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
| Cholesteryl ester transfer protein | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-2 | 1 | 0 | 0 | 1 |
| D-amino-acid oxidase | 0 | 1 | 0 | 1 |
| Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
| Hydroxycarboxylic acid receptor 3 | 0 | 0 | 1 | 1 |
| Nicotinamidase | 0 | 1 | 0 | 1 |
| Hydroxycarboxylic acid receptor 2 | 0 | 0 | 1 | 1 |
| Hydroxycarboxylic acid receptor 2 | 0 | 2 | 1 | 3 |
| D-aspartate oxidase | 0 | 1 | 0 | 1 |
| Hydroxycarboxylic acid receptor 2 | 0 | 1 | 1 | 2 |
| Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
| Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
| Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
| Protease | 0 | 3 | 1 | 4 |
| SMAD family member 2 | 1 | 0 | 0 | 1 |
| PPM1D protein | 2 | 0 | 0 | 2 |
| SMAD family member 3 | 1 | 0 | 0 | 1 |
| estrogen receptor 2 (ER beta) | 4 | 0 | 0 | 4 |
| arylsulfatase A | 3 | 0 | 0 | 3 |
| karyopherin alpha 2 (RAG cohort 1, importin alpha 1), isoform CRA_b | 0 | 0 | 1 | 1 |
| cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
| neuropeptide S receptor isoform A | 1 | 0 | 0 | 1 |
| luciferase | 0 | 0 | 0 | 1 |
| hypoxia-inducible factor 1 alpha subunit | 1 | 0 | 0 | 1 |
| Voltage-dependent calcium channel gamma-2 subunit | 1 | 0 | 0 | 1 |
| Estrogen receptor | 0 | 2 | 0 | 2 |
| Progesterone receptor | 0 | 2 | 0 | 3 |
| Glucocorticoid receptor | 0 | 1 | 1 | 2 |
| Glucocorticoid receptor | 0 | 0 | 1 | 1 |
| Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
| Androgen receptor | 0 | 2 | 0 | 2 |
| Glutamine synthetase | 0 | 0 | 1 | 1 |
| Androgen receptor | 0 | 1 | 0 | 1 |
| Glutamate receptor 2 | 1 | 0 | 0 | 1 |
| Histamine H1 receptor | 0 | 0 | 1 | 1 |
| Nociceptin receptor | 0 | 0 | 1 | 1 |
| Estrogen receptor beta | 0 | 2 | 0 | 2 |
| ATPase family AAA domain-containing protein 5 | 1 | 0 | 0 | 1 |
| Ataxin-2 | 1 | 0 | 0 | 1 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 2 | 0 | 0 | 2 |
| ATAD5 protein, partial | 2 | 0 | 0 | 2 |
| USP1 protein, partial | 1 | 0 | 0 | 1 |
| NAD-dependent protein deacetylase sirtuin-6 | 0 | 1 | 0 | 1 |
| activating transcription factor 6 | 2 | 0 | 0 | 2 |
| Pyridoxal kinase | 0 | 0 | 0 | 1 |
| 15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
| DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
| Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 2 |
| NH(3)-dependent NAD(+) synthetase | 0 | 2 | 0 | 2 |
| 60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2B6 | 0 | 0 | 1 | 1 |
| Arylacetamide deacetylase | 0 | 1 | 0 | 2 |
| Caspase-1 | 0 | 1 | 0 | 1 |
| Alpha-synuclein | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A2 | 0 | 1 | 0 | 1 |
| 10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Glutathione S-transferase omega-1 | 0 | 1 | 0 | 1 |
| DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
| Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| 10 kDa chaperonin | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 3 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 2 | 0 | 3 |
| farnesoid X nuclear receptor | 1 | 0 | 0 | 1 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
| exodeoxyribonuclease V subunit RecD | 0 | 1 | 0 | 1 |
| exodeoxyribonuclease V subunit RecB | 0 | 1 | 0 | 1 |
| exodeoxyribonuclease V subunit RecC | 0 | 1 | 0 | 1 |
| ATP-dependent 6-phosphofructokinase | 0 | 1 | 0 | 1 |
| Dihydropteroate synthase | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
| Dihydrofolate reductase | 0 | 3 | 0 | 4 |
| Endothelin-1 receptor | 0 | 1 | 0 | 1 |
| Chain A, Dihydrofolate Reductase | 0 | 0 | 1 | 1 |
| Chain A, Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Chain A, dihydrofolate reductase (DHFR) | 0 | 1 | 0 | 1 |
| Chain A, Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Chain A, Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 2 |
| Dihydrofolate reductase | 0 | 4 | 0 | 4 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Dihydrofolate reductase type 1 | 0 | 1 | 0 | 2 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 2 | 0 | 2 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 2 | 0 | 2 |
| Dihydrofolate reductase type 1 from Tn4003 | 0 | 1 | 0 | 1 |
| Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
| Metabotropic glutamate receptor 5 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 2 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Trace amine-associated receptor 5 | 0 | 0 | 1 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 2 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Chain A, Trp Rna-binding Attenuation Protein | 0 | 0 | 1 | 1 |
| Chain K, Trp Rna-binding Attenuation Protein | 0 | 0 | 1 | 1 |
| Chain B, tryptophanyl-tRNA synthetase | 0 | 0 | 1 | 1 |
| Chain C, Tryptophanyl-tRNA synthetase II | 0 | 0 | 1 | 1 |
| thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
| Carbonic anhydrase 12 | 0 | 0 | 0 | 1 |
| Plasma kallikrein | 0 | 0 | 0 | 1 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 3 | 0 | 0 | 0 | 1 |
| Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
| Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 2 |
| Carbonic anhydrase 6 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 7 | 0 | 0 | 0 | 1 |
| Tryptophan 2,3-dioxygenase | 0 | 1 | 0 | 2 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 0 | 0 | 1 |
| Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
| SLC16A10 protein | 0 | 0 | 0 | 1 |
| Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 9 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 1 |
| Tryprostatin B synthase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 0 | 0 | 1 |
| 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase | 0 | 0 | 1 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 0 | 0 | 1 |
| Monocarboxylate transporter 10 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 14 | 0 | 0 | 0 | 1 |
| Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 0 | 0 | 1 |
| caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
| caspase-3 | 1 | 0 | 0 | 1 |
| Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
| Urease subunit alpha | 0 | 1 | 0 | 1 |
| Urease subunit beta | 0 | 1 | 0 | 1 |
| Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
| streptokinase A precursor | 0 | 0 | 1 | 1 |
| twin arginine protein translocation system - TatA protein | 0 | 0 | 0 | 1 |
| 30S ribosomal protein S6 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S7 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L15 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L10 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L11 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L7/L12 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L19 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L1 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L20 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L27 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L28 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L29 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L31 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L31 type B | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L32 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L33 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L34 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L35 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L36 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S10 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S11 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S12 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S13 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S16 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S18 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S19 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S20 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S2 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S3 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S4 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S5 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S8 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S9 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L13 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L14 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L16 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L23 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S15 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L17 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L21 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L30 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L6 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S14 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S17 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S1 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L18 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L2 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L3 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L24 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L4 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L22 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L5 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S21 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L25 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L36 2 | 0 | 1 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |